| Product NDC: | 0019-9452 |
| Proprietary Name: | SODIUM IODIDE I 131 |
| Non Proprietary Name: | sodium iodide i 131 |
| Active Ingredient(s): | 1 mCi/mL & nbsp; sodium iodide i 131 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0019-9452 |
| Labeler Name: | Mallinckrodt Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016517 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120125 |
| Package NDC: | 0019-9452-08 |
| Package Description: | 1 CAPSULE in 1 CAN (0019-9452-08) > 8 mL in 1 CAPSULE |
| NDC Code | 0019-9452-08 |
| Proprietary Name | SODIUM IODIDE I 131 |
| Package Description | 1 CAPSULE in 1 CAN (0019-9452-08) > 8 mL in 1 CAPSULE |
| Product NDC | 0019-9452 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium iodide i 131 |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120125 |
| Marketing Category Name | NDA |
| Labeler Name | Mallinckrodt Inc. |
| Substance Name | SODIUM IODIDE I-131 |
| Strength Number | 1 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes | Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] |